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The complete form of androgen insensitivity is an 
inherited X-linked syndrome in which genetic males 
fail to undergo masculinization in utero due to defec- 
tive functioning of the androgen receptor (AR). The 
molecular basis of androgen insensitivity was investi- 
gated in the testicular feminized (Tfm) rat with this 
syndrome. AR mRNA size and amount, as well as nu- 
clear AR protein revealed by immunocytochemistry, 
suggested normal expression of the AR gene in the Tfm 
rat. Sequence analysis of the AR coding region from 
Tfm and wild-type littermate male rats revealed a 
single transition mutation, guanine to adenine, within 
exon E, changing arginine 734 to glutamine within the 
steroid-binding domain of the AR. This arginine is 
highly conserved among the family of nuclear recep- 
tors and may be part of a phosphorylation recognition 
site. A recreated mutant AR (Arg’34 + Gln) expressed 
in COS cells had only lo-15% of the androgen-binding 
capacity of wild-type AR; the reduced androgen-bind- 
ing capacity was similar to that of AR in tissue extracts 
of the Tfm rat. Stimulation of transcriptional activity 
by the recreated mutant AR was reduced relative to 
wild-type AR in cotransfection assays in CVl cells 
using as reporter plasmid the mouse mammary tumor 
virus promoter linked to the chloramphenicol acetyl- 
transferase gene. Thus, arginine 734 appears essential 
for normal AR function both in androgen binding and 
transcriptional activation. Absence of these functions 
results in androgen insensitivity and lack of male sex- 
ual development. 
The X-linked syndrome of androgen insensitivity (known 
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also as testicular feminization (Tfm)‘) results from a failure 
of tissue response to androgen. In the human, phenotypic 
expression ranges from partial forms, in which 46,XY phe- 
notypic males are infertile, to the complete syndrome, in 
which the phenotype is female (1). Androgen insensitivity in 
a strain of King/Holtzman rats was discovered by Stanley 
and Gumbreck and propagated as a substrain (2, 3). Affected 
genetic male rats retain the female phenotype although ab- 
dominal testes produce normal to elevated male levels of 
testosterone, and there is a normal rate of conversion of 
testosterone to dihydrotestosterone (1). In affected genetic 
males, Miillerian ducts are absent because of the effect of 
testicular Miillerian-inhibiting substance, but androgen-de- 
pendent male accessory sex glands fail to develop. 
Cloning of human (4-9) and rat (10) androgen receptor 
(AR) complementary DNA (cDNA) has facilitated the study 
of molecular defects associated with androgen insensitivity. A 
partial deletion (11) and more recently a single base mutation 
(12) in the human AR steroid-binding domain have been 
described in families with the complete syndrome. Naturally 
occurring mutations that result in obvious physiological dis- 
turbances offer the opportunity to discover important struc- 
ture/function relationships in the receptor. In the present 
report, the molecular defect. in the androgen-insensitive Tfm 
rat was investigated at the level of the AR gene and messenger 
RNA (mRNA) expression, subcellular localization of the AR 
protein, and androgen binding and functional properties of 
AR recreated by site-directed mutagenesis. It is demonstrated 
that a single base alteration in the AR gene leads to replace- 
ment of an arginine that is highly conserved within the family 
of nuclear receptors. Androgen binding and functional activi- 
ties of the recreated mutant AR are similar to the activities 
of the Tfm rat AR. 
EXPERIMENTAL PROCEDURES 
Materials-The following reagents were obtained: T4 DNA polym- 
erase and Muta-Gene Ml3 in vitro mutagenesis kit from Bio-Rad: 
Taq polymerase (3.75 units/reaction) from Perkin-Elmer Cetus; nylon 
membranes (Biodyne, O.P-rrrn pore size) from ICN, Irvine, CA: Im- 
mobilon transfer membrane from Millipore; ?-protein A’and’ [3H] 
methyltrienolone (17a-[methyl-3H]R18Sl), 80 Ci/mmol) from Du 
Pont-New England Nuclear; Amplify, 1,2,4,5,6,7-5a-[3H]dihydrotes- 
tosterone (120 Ci/mmol), 32P-dCTP, and YXabeled protein molec- 
ular weight standards from Amersham Corp.; T4 polynucleotide 
kinase, T4 DNA ligase, and Ml3 bacteriophage from New England 
I The abbreviations used are: Tfm, testicular feminization; AR, 
androgen receptor: MMTV-CAT, mouse mammary tumor virus pro- 
motor-linked to the chloramphenicol acetyltransferase gene; R1881, 
methyltrienolone; PCR, polymerase chain reaction; SDS, sodium 
dodecyl sulfate; AA, amino acid(s). 
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BioLabs; avian myeloblastosis virus reverse transcriptase from Life 
Sciences; oligo(dT) from Collaborative Research; isopropyl P-D-thio- 
galactoside and 5-bromo-4-chloro-3-indolyl fl-D-galactoside and most 
restriction enzymes from Bethesda Research Laboratories; glyoxal 
from Fluka Chemical Corp.; W-Omat-AR diagnostic x-ray film from 
Kodak; buffers and chemicals from Fisher or Sigma. 
Vectors and Cell Lines-The wild-type AR expression vector was 
prepared by cloning the full AR coding sequence into the EcoRI site 
of pCMV1. pCMV1 is a eukaryotic expression vector that contains 
the human cytomegalovirus major immediate early gene promoter- 
regulatory region, SV40 origin of replication, and the human growth 
hormone transcription and polyadenylation signals as described pre- 
viously (13). The pCMV vector was kindly provided by Dr. David W. 
Russell, Dept. of Molecular Genetics, University of Texas Health 
Science Center at Dallas. The 7’fm rat AR construct was prepared by 
site-directed mutagenesis as described below. The mouse mammary 
tumor virus-chloramphenicol acetyltransferase reporter plasmid 
(MMTV-CAT) was kindlv provided by Dr. Keith R. Yamamoto. Dept. 
of Biochemistry and Biophysics, University of California, San’ Fran- 
cisco, and has been described (14). 
COS-7 cells are African green monkey kidney cells derived from a 
clone of SV40-transformed CVl cells (15). CVl cells were obtained 
from the American Type Culture Collection. 
Animals-King/Holtzman T/m rats were provided by Dr. Kathie 
L. Olsen, who maintains a breeding colony derived from the originally 
described Tfm Stanlev/Gumbreck rat (2). The genetic male Tfm rat 
lacks Mullerian duct-derivatives, epididymidesr and male accessory 
sex glands. Small abdominal testes produce elevated levels of testos- 
terone (16). For androgen-binding studies, wild-type and Tfm rats 
were castrated and tissues removed as described previously (17). For 
RNA isolation, intact rats were killed by decapitation and the tissue 
removed and immediately frozen in liquid NB. Care of the animals 
was in accordance with institutional guidelines. 
DNA Amplification and Sequencing-Oligonucleotide primers (24- 
33 nucleotide residues in length) homologous to rat AR were synthe- 
sized by Dr. Dana Fowlkes, Dept. of Pathology, University of-North 
Carolina at Chapel Hill, using the phosphoramidite method and an 
Applied Biosystems model 380A DNA synthesizer. The polymerase 
chain reaction (PCR) in 50 mM KCl. 1.5 mM M&l,. 0.01% (w/v) 
gelatin, 10 mM Tris, pH 8.3 (18), was carried out with aPerkin-Elmer 
Cetus thermal cycler using Tag polymerase (3.75 units/reaction). 
Primer and deoxynucleotide triphosphate concentrations were 0.2 
mM. The first coding exon and a portion of the 5’-noncoding region 
(1561 bases in rat AR, intron-exon splice position based on human 
gene sequence; Refs. 5 and 12) were amplified as four overlapping 
fragments from 1 fig of Tfm and wild-type male sibling genomic DNA. 
In four separate reactions, four pairs of oligonucleotides were used as 
primers and 30 cvcles of PCR performed with an extension time of 6 
min + 3 s/cycle at either 67 or-69 “C followed by denaturation for 30 
s at 95 “C. The remaining portion of the AR coding region and part 
of the 3’.noncoding region (1274 bases) were amplified from cDNA 
reverse transcribed(avran myeloblastosis virus reierse transcriptase) 
from 10 ue of Tfm and wild-twe testis ~olv(A) RNA using oligo(dT) 
. I  I  “ _  _  “ .  
as primer (19). Alkaline hydrolysis of the RNA was caryied out in 
0.17 M NaOH for 20 min at 65 “C after the addition of EDTA to a 
concentration of 20 mM. The solution was neutralized with Tris, pH 
7.5, ethanol precipitated, and resuspended in a solution of 0.2 mM 
EDTA, 10 mM Tris, pH 8.0. Forty cycles of PCR (denatured at 95 “C 
for 2 min, annealed at 55 “C for 2 min, and extended at 72 “C for 3 
min 10 s + 3 s/cycle) with buffers and reagents as described above 
were performed on 0.5 rg of single-stranded cDNA to produce a 1.2. 
kilobase fragment that encompassed both the DNA and ligand- 
binding domains. The 1.2-kilobase fragment was electroeluted after 
agarose gel electrophoresis and, in separate reactions, 100 ng sub- 
jected to 30 cycles of the PCR (denatured at 95 “C for 30 s, annealed 
at 55 “C for 1 min. extended at 72 “C for 6 min + 3 s/cycle) to amplify 
the DNA and ligand binding domains. The amplified fragments from 
wild-twe and Tfm rats were blunt end ligated into Ml3 bacterio- 
phage, &-id at least two independent clones-were sequenced using the 
dideoxy method. In areas in which the sequence diverged from that 
of the known Sprague-Dawley or King/Holtzman wild-type sequence, 
both strands were sequenced. 
Site-directed Mutagenesis-A full-length cDNA clone was mutated 
using the oligonucleotide-directed single base mutagenesis method 
described bv Kunkel (20). A full-length AR cDNA was cloned into 
Ml3 bacteriophage and grown in dut-ung- Escherichia coli strain 
CJ236, and single-stranded phage DNA was isolated. An oligonucle- 
otide 26 bases in length (GCCATGGGTTGGCBGTCCTTCACTAA) 
containing the single base mutation of the Tfm rat AR (underlined) 
was phosphorylated and annealed to the single-stranded dUTP- 
containing AR clone in Ml3 as described in the Bio-Rad Muta-Gene 
Ml3 in vitro mutagenesis kit. The complementary strand was syn- 
thesized in uitro using T4 DNA polymerase and ligated using T4 
DNA ligase. Double-stranded circular Ml3 DNA was transfected into 
competent DH5 E. coli, and the replicative plaque-forming bacterio- 
phage Ml3 clones containing AR were isolated after selection using 
isopropyl P-D-thio-galactoside and 5bromo-4-chloro-3-indolyl O-D- 
galactoside. The mutation was confirmed by direct sequencing of 
double-stranded DNA before cloning into the expression vector 
pCMV5 (13). 
Northern. Blot Analysis-Poly(A) RNA was isolated from wild-type 
and Tfm rat kidney (21, 22), denatured with dimethyl sulfoxide and 
glyoxal for 1 h at 50 “C, and fractionated on 1% agarose gels in 10 
mM sodium phosphate, pH 6.8 (23). RNA was transferred to nylon 
membranes (0.2-;rn pore size), cross-linked by exposure to UV light 
for 30 s. and vacuum baked for 1 h at 80 “C. The 5’ EcoRI fragment 
of rat AR cDNA clone rARep1 (10) was labeled with “P-dCTP by 
nick translation (24). Filters were hybridized as described previously 
(24, 25) at 42 “C in the presence of 50% formamide and 0.1% SDS. 
Filters were washed at high stringency (0.1 x SSC; 0.015 M NaCl, 
0.0015 M sodium citrate. oH 7.0. containing 0.1% SDS at 60 “C). 
blotted dry, exposed to Kodak XAR x-ray filmfor l-4 days at -70 “C; 
and processed according to manufacturer’s recommendations. 
Transient Transfection Assays-For androgen binding studies, 
COS-7 cells at 50-75% of confluence were transfected with 1 pg of 
DNA/G-cm dish using the DEAE-dextran method (26). Cells were 
cleared of serum 20 h after transfection and 18 h later were incubated 
with increasing concentrations of [“H]methyltrienolone (R1881) in 
duplicate dishes in the presence and absence of IOO-fold excess 
unlabeled R1881 for 2 h at 37 “C. [‘H]R1881 was used rather than 
[“Hldihydrotestosterone to minimize steroid metabolism during the 
incubation. Cells were washed twice in cold phosphate-buffered saline 
and harvested in 2% SDS, 10% glycerol, and 10 mM Tris, pH 6.8. 
Aliquots were taken for determination of radioactivity and for West- 
ern blot analysis using an antibody specific for AR (10). Specific 
binding was estimated from the difference in radioactivity determined 
in the presence and absence of unlabeled hormone. 
For photoaffinity labeling studies, about 1 X 10s COS-7 cells (60% 
confluence) in lo-cm dishes were treated with 5 pg of vector DNA 
using the DEAE-dextran method (26). Twentv-four h after transfec- 
tionythe medium was changed to serum-free, phenol red-free Dulbec- 
co’s modified Eagle’s medium. Eighteen h later, the medium was 
removed and the cells washed and labeled for 2 h at 37 “C with 12 
nM R1881 with or without a loo-fold excess unlabeled R1881 to assess 
nonspecific binding. Cells were washed in phosphate-buffered saline 
and harvested in SDS sample buffer. For the fluorograph, half of the 
gel was fixed for 30 rnin in isopropyl alcobol/HzO/acetic acid 
(25:65:10) and immersed in Amnlifv for 1 h. The antibodv IgG (10) 
concentration was 11 pg/ml, and 4 ;g peptide/ml was used inpread- 
sorption studies. “C-Labeled molecular weight markers were myosin 
(200,000), phosphorylase b (92,500), bovine serum albumin (69,000), 
ovalbumin (46,000), carbonic anhydrase (30,000), and lysozyme 
(14,300). 
For measurement of AR functional activity, CVl cells were cotrans- 
fected with pCMV expression vector containing either wild-type or 
mutant AR full coding seouence cloned in the EcoRI site and an 
MMTV-CAT reporterplasmid described previously (14). CVl cells 
(1.5 X 10” cells/lO-cm dish) in 5% fetal calf serum and Dulbecco’s 
modified Eagle’s medium were plated to yield approximately 80% of 
confluence for use in transfection 18 h later. Each plasmid (5 Kg) was 
transfected using the calcium phosphate transfection procedure as 
described previously allowing the DNA to incubate with the cells for 
4 h at 37 “C (27). Cells were washed twice with Tris-buffered saline 
(28) and maintained in 0.2% fetal calf serum in Dulhecco’s modified 
Eagle’s medium with or without the addition of R1881 as indicated. 
Forty-eight h after transfection, cells were harvested in phosphate- 
buffered saline and analyzed for chloramphenicol acetyltransferase 
activity as described previously (29). 
Gel Electrophoresis and Immunoblot Analysis-Cell lysates were 
prepared in SDS sample buffer (30) with 3% P-mercaptoethanol and 
boiled for 5 min prior to electrophoresis. Polyacrylamide separating 
gels were 6% acrylamide with a 4% stacking gel as described previ- 
ously (30). Gels were electrophoresed for 700 volt h and transferred 
to Immobilon (0.45 pm) by electroblotting at 4 “C for 480 volt h in 
20% methanol, 0.19 M glycine, and 24 mM Tris, pH 8.3 (31). Filters 
were air dried and incubated with blocking buffer (10% Carnation 
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nonfat dry milk, 0.05? Tween 20, 0.9% NaC1, 10 mM Tris, pH 7.5) 
for 4-6 h with shaking before addition of the IgcI AR antibody (ARl- 
52, 2.8 mg/ml) at a 1:250 dilution (11 fig/ml in 5 ml) in blocking 
buffer. For preadsorption with immunogen, 10 pg of peptide (10) was 
incubated with 20 ~1 of undiluted IgG for 4-6 h on ice followed by 
dilution in blocking buffer as above. Filters were incubated with 
antibody overnight at 4 “C with shaking, washed three times for 5 
min in blocking buffer at room temperature, and incubated with 5 
FCi of “‘I-protem A in 5 ml of blocking buffer for 90 min at room 
temperature. The filters were washed two times for 5 min in blocking 
buffer, five times for 5 min in blocking buffer without Carnation 
milk, and air dried and exposed to x-ray film. The IgcI fractions of 
immune and preimmune sera were obtained by chromatography on 
protein A-agarose as described previously (10). For fluorography, the 
gel was fixed in isopropyl alcohol/HLO/acetic acid (25:65:10) for 30 
min at room temperature and immersed in Amplify for 1.5 h at room 
temperature. The gel was dried and exposed to x-ray film at -70 “C 
for 110 days. 









FIG. 2. Northern blot analysis of kidney RNA from Tfm rat 
and wild-type male siblings. Poly(A) RNA was isolated from 
kidney of Tfm and wild-type sibling rats, and lo-pg aliquots were 
denatured and analyzed by Northern blot hybridization as described 
under “Experimental Procedures.” Shown are Northern blots of 
poly(A) RNA from Tfm (T) and wild-type littermates ( W). Not 
shown is actin cDNA hybridization, which indicated nearly equivalent 
loading of RNA in the two lanes. Molecular weight markers (MW) 
were ‘“P-labeled HindIII-digested X DNA and HaeIII-digested @X174 
DNA. hb. kilobases. 
RESULTS 
AR Gene Structure-The possibility of a major AR gene 
deletion associated with androgen insensitivity in the Tfm rat 
was investigated by Southern blot analysis. Genomic DNA 
isolated from wild-type and Tfm rat liver was digested with 
each of a group of restriction enzymes. The AR gene fragments 
obtained with each enzyme (three shown in Fig. 1) were 
identical electrophoretically using DNA from androgen-insen- 
sitive Tfm and normal male littermate rats. Thus, there was 
no indication of a major deletion or rearrangement of the AR 
gene in the Tfm rat. 
Northern blot analysis of poly(A) RNA revealed a lo- 
kilobase AR mRNA in the Tfm rat which was indistinguish- 
able in size and intensity from wild type (shown in Fig. 2 for 
kidney poly(A) RNA). Smaller size bands were attributed to 
nonspecific interaction of the cDNA probe with ribosomal 
RNA; the ribosomal RNA signal intensity and that observed 
with an actin cDNA probe (not shown) indicated nearly 
equivalent loading of RNA in the two lanes. The characteristic 
lo-kilobase AR mRNA was also observed on Northern blot 
hybridization of RNA extracts from Tfm rat liver, brain, 
submandibular gland, testis, and skeletal muscle (results not 
shown). Thus, AR mRNA abundance and size were consistent 
with normal AR gene transcription and RNA processing in 
the Tfm rat. 
AR Androgen Binding Activity-AR binding of [“Hldihy- 
drotestosterone was measured in kidney cytosol fractions of 
Tfm and wild-type rats using a charcoal adsorption assay (32). 






FIG. 1. Southern blot analysis of genomic DNA from Tfm 
and wild-type littermates. DNA was isolated from liver of Tfm 
(7’) rats and wild-type ( W) siblings. Aliquots of DNA (10 pg) were 
cleaved with GcoRI, HindHI, or HanHI and analyzed on Southern 
blots as described under “Experimental Procedures” using as probe a 
“P-labeled rat AR 5’ BcoRI fragment of the cDNA clone rARep1 
(IO). Additional enzymes used to digest genomic DNA which revealed 
no alteration in fragment sizes between ‘?‘fm and wild-type included 
SacI, KpnI, HaeIII, PstI, and SmaI (not shown). Molecular weight 
markers (MkV) were “P-labeled HindIII-digested X DNA and HaeIII- 
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FIG. 3. Strategy for the polymerase chain reaction and 
DNA sequence analysis of AR DNA. The 3000.base pair AR 
cDNA is shown schematically to include the predicted initiation 
methionine (Met), central DNA binding domain (black box), carboxyl- 
terminal steroid binding region (hatched box), and the termination 
signal (Stop). Wild-type and Tfm rat AR DNAs were amplified using 
PCR. The first: exon was amplified from genomic DNA using four 
sets of oligonucleotide primers (small arrows) yielding amplified 
fragments A370, A471, A520, and A461, where the letter designates 
t.he exon, and the number is the length of the fragment in base pairs. 
The DNA and steroid binding domains and surrounding regions were 
amplified from cDNA that was reverse transcribed from testis poly(A) 
RNA using three sets of oligonucleotides as indicated, yielding am- 
plified fragments A-D486, B-D380, and D-HlK. The DNA sequence 
in the region of the Tfm rat AR single base mutation was confirmed 
by amplification of genomic DNA and direct sequencing (fragment 
E97). At least two independent isolates for each fragment were 
sequenced. 
Specific binding was detectable (l-3 fmol/mg of protein), but 
was only lo-15% of that observed in wild-type siblings and 
too low to determine apparent binding affinity. Thus, the Tfm 
rat AR shows a major reduction in androgen binding. 
Identification of a Single Base Mutation-To identify a 
possible single base mutation or small gene deletion, synthetic 
oligonucleotides homologous to rat AR cDNA (10) were used 
in the polymerase chain reaction to prime the amplification 
of wild-type and Tfm rat, AR DNA and generate overlapping 
fragments within the coding region. Genomic DNA was used 
as template to amplify four fragments from exon A (Fig. 3); 
the remaining coding sequence was amplified from single- 
stranded cDNA obtained by reverse transcription of poly(A) 
RNA. All fragments were cloned into Ml3 bacteriophage and 
sequenced by the dideoxy chain termination method (33). 
Since the Tfm rat derives from the King/Holtzman strain, 
it was necessary to identify first any polymorphic differences 
from the known AR cDNA sequence of the Sprague-Dawley 
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FIG. 4. Full-length coding DNA 
sequence of wild-type King/Holtz- 
man and Tfm rat AR. DNA sequence 
was determined from amplif’ied DNA 
fragments isolated by electroelution 
from 1.4r; (w/v) agarose gels. The DNA 
fragments were phosphorylated (T4 pol- 
ynucleotide kinase) and hlunt end li- 
gated (T4 DNA ligase) into M13mp18 
DNA cleaved with SmaI. Competent 
DH5 E co/l were transformed with the 
Ml3mpl8 DNA, combined with 50 ~1 of 
DH5 E. CO/I cells, and grown overnight 
at 37 “C in media containing 0.83 mM 
isopropyl /j-D-thio-galactoside and 
0.02% 5-bromo-4-chloro-3-indolyl /j-D- 
galactoside. DNA was isolated from 10 
randomly selected clear viral plaques for 
each fragment. At least two independent 
isolates for each fragment were se- 
quenced using the dideoxy chain termi- 
natlon method and “S-labeled dCTP 
(28). Shown is the full coding sequence 
of the King/Holtzman wild-type rat AR 
and the single nucleotide difference in 
the Tfm rat AR sequence. The glutamine 
repeat that differs in length by 1 residue 
and a polymorphic leucine residue that 
differs from serine in the Sprague-Daw- 
ley wild-type rat AR sequence are under- 
irned. Enclosed in a box is the single base 
and amino acid difference between 
King/Holtzman wild-type and Tfm rat 
AR sequence. Amino acid residues are 
numbered above and nucleotides on the 
right, both starting at the predicted ini- 
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FIG. 5. Single base mutation in Tfm rat AR. Shown schemat- 
ically above are the AR functional domains as described in Fig. 4. 
Below are autoradiograms of DNA sequencing gels from coding 
strands of normal male sibling (wild-type) and Tfm male animals 
with the sequencing reactions, guanine (G), adenine (A), thymine 
(7’), and cytosine (C). The DNA sequence shown codes for amino 
acid residues 731-736 of rat AR starting from the lowerportton of the 
gel. A single base change from guanine in wild-type DNA to adenine 
(enwcled) in Tfm rat DNA on the coding strand changes arginine at 
position 734 in wild-type rat AR to glutamine (enclosed in bon) in 
the Tfm rat AR. 
rat (10). The full coding sequence of the wild-type King/ 
Holtzman rat AR was determined as shown in Fig. 4. Com- 
parison with the Sprague-Dawley sequence revealed two 
strain differences. At nucleotide residue 1163, a thymine in 
codon TTG differs from cytosine in the corresponding 
Sprague-Dawley codon TGG, changing serine to leucine at 
amino acid residue 388 in the King/Holtzman rat (shown 
underlined in Fig. 4). This polymorphic change is of no 
Androge” (rat) 
Androgen (human) 
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FIG. 6. Partial amino acid sequence comparisons of nuclear 
receptors within the region of the single base mutation in the 
Tfm AR steroid binding domain. The amino acid (AA) sequence 
of rat AR (AA 731-737) is compared with the corresponding sequence 
of human AR (AA 749-755), Tfm rat AR (AA 730-737), and receptors 
for human progesterone (AA 763-769), glucocorticoid (AA 608-614), 
mineralocorticoid (AA 814-820), estrogen (AA 391-397), retinoic acid 
(AA 243-249), and thyroid hormone (AA 263-269) (Refs. 4-10, 55- 
62). Identical (*) and missing (-) amino acids are indicated relative 
to wild-type rat AR. 
apparent functional significance since both wild-type strains 
produce normal genetic males. Furthermore, like the King/ 
Holtzman strain, leucine occurs at a corresponding position 
in human AR (4-9). Another strain difference was one less 
glutamine in the King/Holtzman rat AR glutamine repeat 
beginning at amino acid residue 174 (shown underlined in Fig. 
4). The lengths of these repeated amino acid motifs in the N- 
terminal region of AR typically vary (4-9), possibly because 
of misincorporation errors intrinsic to cloning. 
Comparison of AR cDNA coding sequences of Tfm and 
wild-type genetic male siblings showed sequence identity 
throughout, with one exception (Figs. 4 and 5). A single base 
change was observed at nucleotide residue 2201, approxi- 
mately one-third the distance (5’-3’) into the steroid-binding 
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FIG. 7. Saturation binding analy- A 30 sis of wild-type and mutant AR cre- 
ated by site-directed mutagenesis in 
M13. A, saturation binding curves for 
wild-type (+) and ‘I@ ( ) rat AR; hind- 20 - 
ing of [ ‘H]R1881 was determined as de- 
Wild Type (Kd= 2 6 nM) 
scribed under “Experimental Proce- Bound ( pmol) 
dures.” Inset, immunohlot of equivalent 
aliquots of cells transfected with wild- 
type Cleft) and ?‘fm (rrghl) rat AR DNA 
expression vectors performed as de- 
scribed under “Experimental Proce- 
dures.” H. Scatchard plot of wild-type nn 1,T (*) and 7’fm ( ) rat AR binding. Stand- 
ard deviation of the binding constants 
was +1.3 nM. 
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FIN;. 8. Photoaffinity labeling of transiently expressed AR 
with sequence of wild-type (WT) and Tfm rat AR. COS-7 cells 
were transiently transfected with pCMV expression vector containing 
either wild-type or 7’fm rat AR full-length coding sequence as de- 
scribed under “Experimental Procedures.” Approximately 125 gg of 
protein was applied to each lane for the fluorograph and 65 pg of 
protein to each lane for the immunoblot. The gel for fluorography 
was exposed to XAR-5 x-ray film for 110 days at -80 “C and the 
immunohlot for 3 days. Electrophoretic procedures and molecular 
weight markers are as described under “Experimental Procedures.” 
Specificity was demonstrated in the immunohlot by peptide adsorp- 
tion of the I& antibody faction (peptzde competed) and in the 
fluorograph. by labeling in the presence of a loo-fold M excess of 
unlabeled R1881 (RI881 competed) as described under “Experimental 
Procedures.“ 
domain. The G (wild type) to A (Tfm) mutation resulted in 
conversion of highly basic arginine (codon CGG) to neutral 
glutamine (codon CAG) at amino acid residue 734 (Fig. 5). 
Confirmation of the mutation was obtained by PCR amplifi- 
cation and sequencing genomic DNA from individual Tfm 
male rats as shown schematically in Fig. 3. The single base 
mutation occurs within exon E of the AR gene based on 
sequence homology and exon positioning of the human AR 
gene (12). 
Sequence Homologies-Arginine 734, which is replaced by 
glutamine in the Tfm rat AR, is positionally conserved 
throughout the nuclear receptor family (Fig. 6). Arginine at 
this position appears critical therefore to the function of this 
group of nuclear proteins. Interestingly, it is adjacent to an 
almost equally conserved serine residue (Fig. 6); together, 
they may form a recognition sequence for phosphorylation. 
The conserved arginine is probably not a determinant of 
ligand binding specificity since it occurs among receptors that 
bind diverse ligands. However, the low level of androgen 
binding by the Tfm rat AR suggests that the arginine is 
3-HRl881 (nM) ” I z 3 3 
Bound ( pmol) 
essential for normal steroid binding capacity. 
Recreation and Expression of the Mutant Receptor-As 
proof that the G to A transition mutation at nucleotide 2201 
caused the functional defect in AR, site-directed mutagenesis 
was performed in Ml3 bacteriophage using wild-type rat AR 
cDNA as template for DNA synthesis, and as primer, a single- 
stranded oligonucleotide containing the mutant sequence. 
Mutant and wild-type AR cDNAs were cloned into pCMV 
and expressed in COS-7 cells. A striking reduction in binding 
capacity (about lo-fold) was observed with the mutant AR 
(Fig. 7, A and B), even though the amount of mutant AR 
protein expressed in COS cells was equivalent to wild type as 
determined by immunoblot analysis (see inset, Fig. 7A). In- 
terestingly, the mutant AR had an apparent affinity for 
R1881, a synthetic androgen, equivalent to that of the wild- 
type receptor (Fig. 7B) despite its low binding capacity. No 
specific binding was measured in mock transfected COS cells. 
Photoaffinity [“H]R1881 labeling of wild-type and recreated 
Tfm AR showed a striking reduction in labeling of Tfm rat 
AR (Fig. 8, fluorograph), even though transfected COS cells 
contained similar levels of expressed wild-type and mutant 
AR protein, respectively (Fig. 8, immunoblot). Preadsorption 
of the IgG fraction with the peptide immunogen (10) elimi- 
nated antibody reactivity with the 114,000 and 70,000 molec- 
ular weight protein bands. Similarly, a loo-fold excess of 
unlabeled R1881 eliminated the binding of [“H]R1881 to both 
protein bands. Thus, the 114,000 and 70,000 protein bands 
likely represent AR, the smaller probably resulting from either 
proteolytic degradation or from an alternate translation ini- 
tiation site. 
The reduced photoaffinity labeling of the recreated Tfm rat 
AR is consistent with the low binding capacity observed by 
Scatchard plot analysis (see Fig. 7) and the low level of 
androgen binding observed in kidney cytosol of the Tfm rat. 
The reduced binding capacity of the recreated Tfm rat AR is, 
in fact, similar to the low or undetectable binding reported 
previously for endogenous Tfm male rat AR (34-36). The rat 
pituitary gland AR of the Tfm rat was found to have low 
binding capacity but to retain normal binding affinity for [“HI 
testosterone (35). Thus, both the Tfm rat AR and the recre- 
ated mutant AR have reduced androgen binding capacity with 
affinity equivalent to that of wild-type AR. 
Immunocytochemical Localization-Subcellular localization 
of the Tfm rat AR was examined by immunocytochemical 
staining in pituitary, testis, and brain using an AR-specific 
antibody described previously (10). As in wild-type rat tissues, 
AR in the Tfm rat was present in nuclei (illustrated by the 
pituitary in Fig. 9). Staining intensity of AR was indistin- 
guishable from wild-type littermate males (not shown). The 
finding of nuclear AR protein in the Tfm rat would appear to 
contradict previous biochemical evidence that [“Hltestoster- 
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FIG;. 9 Immunocytochemical lo- 
calization of AK in Tfm male rat 
pituitary gland. Adult ?‘f,n rats re- 
cel\ed <I I.5In:: infection of tehtosterone 
prop~onat e 111 sewme 011 mt ramuscularl~ 
16 h prior to tlhhue removal and rapld 
Iree7lng. Treatment with the high dose . 
01 te5toiterone prop10n”te was to en- , - 
hance AR occupant\ and recognltlon h) 
the antihod?. Frozen \ectlons (6 pm) of 
pltultar\ Isere mcuhated tvlth the IgG 
lract 1on of androgen receptor antlhod> 
(/c/t ) or prem,mune serum ( r~:‘llt) and 
\talned In the a\ IdIn-l)lotln-I)erosldase 
met hod (63). The antIhotly ARl-.i? was 
r,used agalnht a i> nthetlc peptIde with 
sequence Ju5t 5’ of the AR DNA handing r 
domain (10) \+ hlch 15 not in the re:lon 
of the ‘f/m rat AR mutation. The IgG 
tract ion wai prepared (10) and used at a 
dllutlon of 5 pg/rnl of protein. Magnif’l- 
c’ltlon x 690. < . L 
IMMUNE IgG PREIMMUNE IgG 
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“l+li a - - + RI881 
0 
Flc:. 10. A functional assay for AK by cotransfection with 
the IMMTV-CAT reporter plasmid. CVl cells were transfected 
wclth wlcl-type and the recreated mutant AR expresslon vectors in 
pCM\’ together wth the MMTY-CAT reporter plasmld as descrlhed 
under “Expermiental I’rocedureh.” After transfection, cells were 
mamtamed m 0.2’~ fetal calf’ serum in Dulhecco’s modified Eagle’s 
medium wth or wIthout the addltmn of .X nbt R1881. Shown 1s the 
fluorogram of chloramphemcol acet~ltransierase activity separated 
Into Its acetylated forms h> sdica plate chromatography for lnnc 1, 
pCM\’ parent plasmid lacklng AR heyuence: lane 2, wild-type AR 
wt hout androgen; /once 3, wild-type AR wth androgen treatment: 
/CIVIC -1, ‘I’fm mutant AR without androgen; and lanr 5, 7’/tn mutant 
AR ulth anclrogen treatment. The rewlth are representatlre of f’our 
independent experiments. 
one does not accumulate in nuclei of the Tfm male rat in uiuo 
(35-39); however, the results can be explained by a mutant 
AR with low androgen binding capacity. 
J’unctional A&i&-The transcriptional activation func- 
tion of the Tfm rat AR was tested by cotransfection into CVl 
cells of the parent vector or expression vectors containing the 
mutant or wild-type AR together with an MMTV-CAT re- 
porter plasmid. It was shown previously that AR in the 
presence of androgen stimulates transcriptional activity of 
the enhancer/promoter of the MMTV long terminal repeat 
(40-43). As shown in Fig. 10, CV1 cells transfected with wild- 
type AR respond to androgen with an increase in chloram- 
phenicol acetyltransferase activity. In CVl cells expressing 
the recreat,ed mutant receptor, chloramphenicol acetyltrans- 
ferase activity following androgen stimulation was lower than 
wild type. Thus, the arginine to glutamine mutation of the 
Tfm rat reduces both androgen binding capacity and func- 
tional activity, although AR is localized in the nucleus. 
DISCUSSION 
This study has established the molecular basis of androgen 
insensitivity in the Stanley/Gumbreck Tfm rat and has 
thereby revealed the functional importance of an amino acid 
within the steroid binding domain that is absolutely conserved 
among the family of nuclear receptors. Recreation of the Tfm 
rat AR by site-directed mutagenesis resulted in a receptor 
with identical properties, including greatly reduced androgen 
binding capacity and reduced function as a transcriptional 
activator. 
Previous reports describing the hormonal responses of the 
Tfm rat present somewhat contradictory findings. Tfm male 
rats are unresponsive to physiological concentrations of an- 
drogen (34), and hence the androgen insensitivity syndrome 
develops. However, pharmacological doses of testosterone (44) 
and dihydrotestosterone (35) can induce detectable biological 
effects. For example, serum luteinizing hormone levels were 
decreased in Tfm males in response to high doses of androgen 
in a manner similar to the normal feedback effect in the wild- 
type rat at physiological androgen levels (35). Similarly, high 
doses of androgen induced preputial gland growth in the Tfm 
rat (44). In the present report, the Tfm rat AR is localized in 
the nucleus in the presence of androgen at high levels, and a 
high androgen concentration in CVl cells induced a low level 
of chloramphenicol acetyltransferase activity in cotransfec- 
tion assays. 
These observations could be accounted for by the low 
amount of high affinity binding by AR which persists in the 
Tfm rat. An AR with reduced androgen binding capacity may 
be insufficient to elicit androgen responses at physiological 
hormone concentrations, whereas a high concentration of 
androgen may stabilize nuclear interactions of the defective 
AR, perhaps including that fraction of AR with binding activ- 
ity below the level of detection in our assay. Thus, even with 
their reduced binding capacity, the Tfm rat AR (35) and the 
recreated mutant AR are functionally active in the presence 
of pharmacological levels of androgen. 
On the other hand, androgen withdrawal by castration does 
not increase AR mRNA in Tfm rat kidney as observed in the 
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wild-type rat, and treatment with high doses of testosterone 
propionate (10 mg intramuscularly) did not down-regulate AR 
mRNA (16). It is possible that the inhibitory function of the 
receptor involves different mechanisms that cannot be com- 
pensated for by high dose androgen. Testosterone effects on 
sexual behavior in the Tfm rat have been attributed to the 
conversion of testosterone to estrogen in the brain; male type 
sexual behavior occurs to a limited extent in response to 
estrogen or testosterone, but not to dihydrotestosterone, a 
nonaromatizable androgen (45, 46). 
Why the recreated Tfm rat AR mutation is expressed as 
two populations of receptors, i.e. a small amount of receptor 
that retains high affinity androgen binding and a larger 
amount with undetectable binding, is not presently under- 
stood. However, adjacent to arginine 734 in AR are potential 
phosphorylation sites (47) on serine or threonine. In addition, 
a partially conserved tyrosine occurs in the region in other 
members of the nuclear receptor family (see Fig. 6). Arginine 
734 may be a necessary basic amino acid in a phosphorylation 
recognition sequence, and its loss may result in inefficient 
phosphorylation, possibly on the highly conserved serine 735 
or threonine 737. It was demonstrated recently that a decrease 
in tyrosine phosphorylation in the steroid binding domain of 
the estrogen receptor greatly decreases estradiol binding ca- 
pacity without changing binding affinity (48). The difference 
in estradiol binding of nonphosphorylated and phosphoryl- 
ated estrogen receptors as shown by Scatchard plot analysis 
(48) was quite similar to the androgen binding of mutant and 
wild-type rat AR observed in this report. Thus, a hypothesis 
to be tested further is that the arginine 734 to glutamine 
mutation in the Tfm rat AR prevents phosphorylation at one 
or more critical sites in the steroid-binding domain. Other 
possible consequences of the single base mutation include 
distortion of protein folding and/or loss of dimer formation 
or interactions with other proteins (49-51). 
Most steroid binding domain mutations disrupt steroid 
binding activity and/or transcriptional activity, indicating 
that much of the carboxyl-terminal region is important for 
receptor function (52-54). The present study indicates that a 
single base mutation within the AR steroid binding domain 
greatly reduces androgen binding capacity. Arginine at posi- 
tion 734 is involved in one or more mechanisms required for 
normal functioning of the androgen binding domain. Natu- 
rally occurring AR mutations associated with androgen insen- 
sitivity provide experimental models that serve as guides in 
correlating structural, physiological, developmental, and be- 
havioral aspects of receptor function. 
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